Connection
Vivian Shi to Antibodies, Monoclonal
This is a "connection" page, showing publications Vivian Shi has written about Antibodies, Monoclonal.
|
|
Connection Strength |
|
|
|
|
|
1.278 |
|
|
|
-
Maarouf M, Alexander C, Shi VY. Nivolumab reactivation of hypertrophic lichen planus, a case report and review of published literature. Dermatol Online J. 2018 Jan 15; 24(1).
Score: 0.444
-
Maarouf M, Clark AK, Lee DE, Shi VY. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. J Dermatolog Treat. 2018 Aug; 29(5):441-449.
Score: 0.439
-
Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):19-28.
Score: 0.126
-
Hendricks AJ, Shi VY. Learning About Dupilumab-Associated Conjunctivitis. JAMA Dermatol. 2019 06 01; 155(6):754.
Score: 0.122
-
Lee DE, Clark AK, Tran KA, Shi VY. New and emerging targeted systemic therapies: a new era for atopic dermatitis. J Dermatolog Treat. 2018 Jun; 29(4):364-374.
Score: 0.109
-
Shih T, Lee K, Grogan T, De DR, Shi VY, Hsiao JL. Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis. Dermatol Ther. 2022 09; 35(9):e15691.
Score: 0.038